These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10928465)

  • 1. Homocysteine as a risk factor for restenosis after coronary angioplasty.
    Morita H; Kurihara H; Kuwaki T; Hamada C; Kitaoka M; Suzuki S; Yazaki Y; Nagai R
    Thromb Haemost; 2000 Jul; 84(1):27-31. PubMed ID: 10928465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia and restenosis.
    Kumbasar SD; Dinçer I; Ertas F; Gülec S; Erol C; Akyürek O; Kiliçkap M; Oral D; Sipahi E; Laleli Y
    J Cardiovasc Risk; 2001 Feb; 8(1):9-13. PubMed ID: 11234727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of plasma homocysteine with restenosis after percutaneous coronary angioplasty.
    Schnyder G; Roffi M; Flammer Y; Pin R; Hess OM
    Eur Heart J; 2002 May; 23(9):726-33. PubMed ID: 11977999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.
    Miner SE; Hegele RA; Sparkes J; Teitel JM; Bowman KA; Connelly PW; Banijamali H; Lau HK; Chisholm RJ; Babaei S; Strauss BH
    Am Heart J; 2000 Aug; 140(2):272-8. PubMed ID: 10925342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis after transluminal coronary angioplasty: a risk factor analysis.
    Gürlek A; Dağalp Z; Oral D; Omürlü K; Erol C; Akyol T; Tutar E
    J Cardiovasc Risk; 1995 Feb; 2(1):51-5. PubMed ID: 7606641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restenosis in Intervened Coronaries with Hyperhomocysteinemia (RICH).
    Kojoglanian SA; Jorgensen MB; Wolde-Tsadik G; Burchette RJ; Aharonian VJ
    Am Heart J; 2003 Dec; 146(6):1077-81. PubMed ID: 14661002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD).
    Abbate R; Sardi I; Pepe G; Marcucci R; Brunelli T; Prisco D; Fatini C; Capanni M; Simonetti I; Gensini GF
    Thromb Haemost; 1998 Apr; 79(4):727-30. PubMed ID: 9569181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and restenosis after percutaneous coronary intervention.
    Mahanonda N; Leowattana W; Kangkagate C; Lolekha P; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S636-44. PubMed ID: 12002904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of antibodies to heat-shock protein-65 with percutaneous transluminal coronary angioplasty and subsequent restenosis.
    Mukherjee M; De Benedictis C; Jewitt D; Kakkar VV
    Thromb Haemost; 1996 Feb; 75(2):258-60. PubMed ID: 8815572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    Schnyder G; Roffi M; Pin R; Flammer Y; Lange H; Eberli FR; Meier B; Turi ZG; Hess OM
    N Engl J Med; 2001 Nov; 345(22):1593-600. PubMed ID: 11757505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of predictive factors associated with recurrent restenosis after second percutaneous transluminal coronary angioplasty].
    Kishi K; Hiasa Y; Tanaka H; Kinoshita M; Tanimoto M; Wada T; Aihara T
    J Cardiol; 1997 Jan; 29(1):7-12. PubMed ID: 9023674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine and risk of recurrent stroke.
    Boysen G; Brander T; Christensen H; Gideon R; Truelsen T
    Stroke; 2003 May; 34(5):1258-61. PubMed ID: 12702838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis.
    Hojo Y; Ikeda U; Katsuki T; Mizuno O; Fukazawa H; Kurosaki K; Fujikawa H; Shimada K
    Heart; 2000 Jul; 84(1):83-7. PubMed ID: 10862597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis after percutaneous transluminal coronary angioplasty in patients with non-insulin-dependent diabetes mellitus (NIDDM).
    Asakura Y; Suzuki M; Nonogi H; Haze K; Sato A; Inada H; Okuda Y; Yamashita K; Harano Y
    J Cardiovasc Risk; 1998; 5(5-6):331-4. PubMed ID: 9920005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty.
    Hokimoto S; Ogawa H; Saito T; Oshima S; Noda K; Soejima H; Takazoe K; Date H; Ishibashi F; Nakamura S; Yasue H
    Jpn Circ J; 2000 Nov; 64(11):831-4. PubMed ID: 11110426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of enhanced insulin secretion during an oral glucose tolerance test as a predictor of restenosis after direct percutaneous transluminal coronary angioplasty during acute myocardial infarction in patients without diabetes mellitus.
    Osanai H; Kanayama H; Miyazaki Y; Fukushima A; Shinoda M; Ito T
    Am J Cardiol; 1998 Mar; 81(6):698-701. PubMed ID: 9527077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis].
    Ishikawa Y; Fujioka Y; Kitagawa Y; Nobusawa A; Takahashi A; Taniguchi T; Yokoyama M
    Nihon Ronen Igakkai Zasshi; 1995 Jul; 32(7):491-6. PubMed ID: 7500552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
    Kalita J; Kumar G; Bansal V; Misra UK
    Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.